Bulletin of the Korean Chemical Society

Korean Chemical Society (대한화학회)
권호 표지
DOI QR코드

DOI QR Code

Novel 3-Methyl-4-(O-substituted-oximino)-pyrazolin-5-ones as a Potent Inhibitors of Cdc25B Phosphatase

  • Seo, Min-Jung (Medicinal Science Division, Korea Research Institute of Chemical Technology) ;
  • Kim, Jung-Ki (Medicinal Science Division, Korea Research Institute of Chemical Technology) ;
  • Son, Bum-Suk (Medicinal Science Division, Korea Research Institute of Chemical Technology) ;
  • Song, Bo-Gan (Medicinal Science Division, Korea Research Institute of Chemical Technology) ;
  • No, Zae-Sung (Medicinal Science Division, Korea Research Institute of Chemical Technology) ;
  • Cheon, Hyae-Gyeong (Medicinal Science Division, Korea Research Institute of Chemical Technology) ;
  • Kim, Kwang-Rok (Medicinal Science Division, Korea Research Institute of Chemical Technology) ;
  • Sohn, Young-Sun (CJ Corp.) ;
  • Kim, Hyoung-Rae (Medicinal Science Division, Korea Research Institute of Chemical Technology)
  • Published : 2004.08.20
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Donzelli, M.; Draetta, G. F. EMBO Rep. 2003, 4, 671. https://doi.org/10.1038/sj.embor.embor887
  2. Nilsson, I.; Hoffmann, I. Prog. Cell Cycle Res. 2000, 4, 107.
  3. Hoffmann, I.; Draetta, G. F.; Karsenti, E. EMBO J. 1994, 13,4302.
  4. Lammer, C.; Wagerer, S.; Saffrich, R.; Mertents, D.;Ansorge, W.; Hoffmann, I. J. Cell Sci. 1998, 111, 2445.
  5. Millar,J. B.; Blevitt, J.; Gerace, L.; Sadhu, K.; Featherstone, C.; Russell,P. Proc. Natl. Acad. Sci. U. S. A. 1991, 88, 10500. https://doi.org/10.1073/pnas.88.23.10500
  6. Takemasa, I.; Yamamto, H.; Sekimoto, M.; Ohue, M.; Noura,S.; Miyake, Y.; Matsumoto, T.; Aihara, T.; Tomita, N.; Tamaki, Y.;Sakita, I.; Kikkawa, N.; Matsuura, N.; Shiozaki, H.; Monden, M.Cancer Res. 2000, 60, 3043.
  7. Nishioka, K.; Doki, Y.; Shiozaki,H.; Yamamoto, H.; Tamura, S.; Yasuda, T.; Fujiwara, Y.; Yano,M.; Miyata, H.; Kishi, K.; Nakagawa, H.; Shamma, A.; Monden,M. British J. Cancer 2001, 85, 412. https://doi.org/10.1054/bjoc.2001.1934
  8. Kudo, Y.; Yasui, W.; Ue,T.; Yamamoto, S.; Yokozaki, H.; Nikai, H.; Tahara, E. Jpn. J.Cancer Res. 1997, 88, 947. https://doi.org/10.1111/j.1349-7006.1997.tb00313.x
  9. Broggini, M.; Buraggi, G.; Brenna,A.; Riva, L.; Codegoni, A. M.; Torri, V.; Lissoni, A. A.; Mangioni,C.; DIncalci, M. Anticancer Res. 2000, 20, 4835.
  10. Nagan, E. S.W.; Hashimoto, Y.; Ma, Z.-Q.; Tsai, M.-J.; Tsai, S.-Y. Oncogene2003, 22, 734. https://doi.org/10.1038/sj.onc.1206121
  11. Tang, L.; Li, G.; Tron, V. A.; Trotter, M. J.; Ho.V. C. Melanoma Res. 1999, 9, 148. https://doi.org/10.1097/00008390-199904000-00006
  12. Ma, Z. Q.; Chua, S. S.; DeMayo, F. J.; Tsai, S. Y. Oncogene1999, 18, 4564. https://doi.org/10.1038/sj.onc.1202809
  13. Yao, Y.; Slosberg, E. D.; Wang, L.; Hibshoosh,H.; Zhang, Y. J.; Xing, W. Q.; Santella, R. M.; Weinstein, I. B.Oncogene 1999, 18, 5159. https://doi.org/10.1038/sj.onc.1202908
  14. Ham, S. W.; Park, J.; Lee, S.; Kim, W.; Kang, K.; Choi, K. H.Bioorg. Med. Chem. Lett. 1998, 8, 2507. https://doi.org/10.1016/S0960-894X(98)00411-9
  15. Lazo, J. S.; Aslan, D.C.; Southwick, E. C.; Cooley, K. A.; Ducruet, A. P.; Joo, B.; Vogt,A.; Wipf, P. J. Med. Chem. 2001, 44, 4042. https://doi.org/10.1021/jm0102046
  16. Lazo, J. S.;Nemoto, K.; Pestell, K. E.; Cooley, K.; Southwick, E. C.;Mitchell, D. A.; Furey, W.; Gussio, R.; Zaharevitz, D. W.; Joo, B.;Wipf, P. Mol. Pharm. 2002, 61, 702.
  17. Wipf, P.; Hopkins, C. R.;Phillips, E. O.; Lazo, J. S. Tetrahedron 2002, 58, 6367. https://doi.org/10.1016/S0040-4020(02)00636-1
  18. Fritzen, E. L.; Brightwell, A. S.; Erickson, L. A.; Romero, D. L.Bioorg. Med. Chem. Lett. 2000, 10, 649. https://doi.org/10.1016/S0960-894X(00)00069-X
  19. Otani, T.; Sugimoto, Y.; Aoyagi, Y.; Igarashi, Y.; Furumai, T.; Saito,N.; Yamada, Y.; Asao, T.; Oki, T. J. Antibiotics 2000, 53, 337. https://doi.org/10.7164/antibiotics.53.337
  20. Ducruet, A. P.; Rice, R. L.; Tamura, K.; Yokokawa, F.; Yokokawa,S.; Wipf, P.; Lazo, J. S. Bioorg. Med. Chem. 2000, 8, 1451. https://doi.org/10.1016/S0968-0896(00)00069-9
  21. Vicentini, C. B.; Veronese, A. C.; Giori, P.; Baraldi, P. G.; Guarneri, M. International J. Peptide & Protein Research 1980, 16, 48.
  22. Jelich, K.; Kraemer, W.; Brandes, W.; Haenssler, G.; Reinecke, P. U. S. Pat. 1987, 4666933 A.

Cited by

  1. Catalyst selective and regiodivergent O- to C- or N-carboxyl transfer of pyrazolyl carbonates: synthetic and computational studies vol.5, pp.9, 2014, https://doi.org/10.1039/C4SC00879K
  2. Oximes of five-membered heterocyclic compounds with two heteroatoms 2. Reactions and biological activity (Review) vol.43, pp.8, 2007, https://doi.org/10.1007/s10593-007-0151-5
  3. New one-pot synthesis of 4-hydroxyimino-5-polyfluoroalkylpyrazol-3-ones, their structure and biological activity pp.1573-8353, 2019, https://doi.org/10.1007/s10593-019-02418-4